Distillate Capital Partners »

ResMed shares owned by Distillate Capital Partners

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Distillate Capital Partners from 13F filings

Historical chart of Distillate Capital Partners investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Distillate Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Distillate Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $16M 67k 240.87

More positions owned by Distillate Capital Partners

Abbvie (ABBV)
Merck & Co (MRK)
Metropcs Communications (TMUS)
Procter & Gamble Company (PG)
Johnson & Johnson (JNJ)
Cisco Systems (CSCO)
salesforce (CRM)
Comcast Corp Cl A (CMCSA)
Bristol Myers Squibb (BMY)
Qualcomm (QCOM)
Accenture Plc Ireland Shs Class A (ACN)
Uber Technologies (UBER)
Cigna Corp (CI)
Amgen (AMGN)
Booking Holdings (BKNG)

View all positions for Distillate Capital Partners

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Invesco
Northern Trust
First Trust Advisors
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Swedbank AB
Nordea Investment Management Ab
Norges Bank Investment Management
Legal & General Group
Dimensional Fund Advisors

View all funds holding ResMed